SCHEMBL3396083

SCHEMBL3396083

COc1cc(Cn2cnc3c(OC)ncnc32)c(Br)c(OC)c1OC

nearest known ligand 0.71

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.71
HSP90AB1 P08238 11/20 0.71
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44
HPGD P15428 1/20 0.43
DAPK1 P53355 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
PDE5A O76074 1/20 0.39
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395258 0.83 HSP90AB1 (1.00) HSP90AA1HSP90AB1
SCHEMBL3393884 0.83 HSP90AA1 (0.48) HSP90AA1HSP90AB1FLT4KDRHPGD
SCHEMBL3395811 0.83 HSP90AA1 (0.57) HSP90AA1HSP90AB1FLT4KDRHPGD
SCHEMBL3396045 0.77 HSP90AB1 (1.00) HSP90AA1HSP90AB1
SCHEMBL3389641 0.77 HSP90AB1 (1.00) HSP90AA1HSP90AB1
SCHEMBL3396138 0.76 HSP90AA1 (0.66) HSP90AA1HSP90AB1PDE5A
SCHEMBL3396299 0.75 HSP90AB1 (1.00) HSP90AA1HSP90AB1
SCHEMBL3395476 0.75 HSP90AB1 (0.80) HSP90AA1HSP90AB1
SCHEMBL3393834 0.72 HSP90AB1 (0.74) HSP90AA1HSP90AB1
SCHEMBL17364335 0.72 ADORA2A (0.60) FLT4KDRHPGDDAPK1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2145888-A1 Deazapurine derivatives as HSP90-Inhibitors Conforma Therapeutics Corporation (US) 2010-01-20 EP disclosed
EP-1670802-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS Conforma Therapeutic Corporation (US) 2006-06-21 EP disclosed
WO-2005028434-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2005-03-31 WO disclosed